[EN] DGK TARGETING COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS DE CIBLAGE DE DGK ET UTILISATIONS ASSOCIÉES
申请人:[en]ARVINAS OPERATIONS, INC.
公开号:WO2023150186A1
公开(公告)日:2023-08-10
Disclosed herein are compounds of Formula (A), or a pharmaceutically acceptable salt thereof, which inhibit the activity of one or both of diacylglycerol kinase alpha (DGKα). These compounds are useful in the treatment of proliferative diseases (e.g., cancer) and viral infections.
Identification and characterization of amino-piperidinequinolones and quinazolinones as MCHr1 antagonists
作者:Christopher Blackburn、Matthew J. LaMarche、James Brown、Jennifer Lee Che、Courtney A. Cullis、Sujen Lai、Martin Maguire、Thomas Marsilje、Bradley Geddes、Elizabeth Govek、Vivek Kadambi、Colleen Doherty、Brian Dayton、Sevan Brodjian、Kennan C. Marsh、Christine A. Collins、Philip R. Kym
DOI:10.1016/j.bmcl.2006.02.044
日期:2006.5
Several potent, functionally active MCHr1antagonists derived from quinolin-2(1H)-ones and quinazoline-2(1H)-ones have been synthesized and evaluated. Pyridylmethyl substitution at the quinolone 1-position results in derivatives with low-nM binding potency and good selectivity with respect to hERG binding.